Media coverage about Genesis Healthcare (NYSE:GEN) has trended somewhat positive on Monday, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Genesis Healthcare earned a news impact score of 0.10 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.3882904689313 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the news articles that may have impacted Accern Sentiment’s scoring:

Several research firms have weighed in on GEN. Royal Bank Of Canada reiterated a “hold” rating and set a $2.00 target price on shares of Genesis Healthcare in a report on Wednesday, September 13th. ValuEngine lowered Genesis Healthcare from a “sell” rating to a “strong sell” rating in a report on Thursday, July 13th.

Shares of Genesis Healthcare (NYSE GEN) traded up $0.03 during trading hours on Monday, hitting $0.98. The stock had a trading volume of 117,943 shares, compared to its average volume of 264,241. Genesis Healthcare has a 12 month low of $0.91 and a 12 month high of $4.75. The company has a debt-to-equity ratio of -5.49, a current ratio of 1.26 and a quick ratio of 1.26.

ILLEGAL ACTIVITY NOTICE: This story was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at

Genesis Healthcare Company Profile

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.